{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:32:56Z","timestamp":1790127176371,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangxi Provincial Administration of Traditional Chinese Medicine Science and Technology Plan Project","award":["2020A0258"],"award-info":[{"award-number":["2020A0258"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86733-1","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T06:26:15Z","timestamp":1737354375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Investigation of Scutellaria Barbata\u2019s immunological mechanism against thyroid cancer using network pharmacology and experimental validation"],"prefix":"10.1038","volume":"15","author":[{"given":"Gen","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuangui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhehao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"Suppl 7","key":"86733_CR1","doi-asserted-by":"publisher","first-page":"vii110","DOI":"10.1093\/annonc\/mds230","volume":"23","author":"F Pacini","year":"2012","unstructured":"Pacini, F., Castagna, M. G., Brilli, L. & Pentheroudakis, G. Thyroid cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 23 (Suppl 7), vii110\u2013119 (2012).","journal-title":"Ann. Oncol."},{"key":"86733_CR2","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1089\/thy.2018.0579","volume":"29","author":"M Abu-Helalah","year":"2019","unstructured":"Abu-Helalah, M. et al. A cross-sectional study to assess the prevalence of adult thyroid dysfunction disorders in Jordan. Thyroid 29, 1052\u20131059 (2019).","journal-title":"Thyroid"},{"key":"86733_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1530\/ERC-19-0292","volume":"26","author":"RK Orosco","year":"2019","unstructured":"Orosco, R. K. et al. Radioactive iodine in differentiated thyroid cancer: a national database perspective. Endocr. Relat. Cancer. 26, 795\u2013802 (2019).","journal-title":"Endocr. Relat. Cancer"},{"key":"86733_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10552-008-9260-4","volume":"20","author":"BA Kilfoy","year":"2009","unstructured":"Kilfoy, B. A. et al. International patterns and trends in thyroid cancer incidence, 1973\u20132002. Cancer Causes Control. 20, 525\u2013531 (2009).","journal-title":"Cancer Causes Control"},{"key":"86733_CR5","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1245\/s10434-014-4209-1","volume":"22","author":"L Enewold","year":"2015","unstructured":"Enewold, L., Harlan, L. C., Stevens, J. L. & Sharon, E. Thyroid cancer presentation and treatment in the United States. Ann. Surg. Oncol. 22, 1789\u20131797 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"86733_CR6","doi-asserted-by":"publisher","first-page":"100939","DOI":"10.1016\/j.drup.2023.100939","volume":"68","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy. Drug Resist. Updat. 68, 100939 (2023).","journal-title":"Drug Resist. Updat"},{"key":"86733_CR7","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1089\/thy.2020.0322","volume":"31","author":"C Dierks","year":"2021","unstructured":"Dierks, C. et al. Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma. Thyroid 31, 1076\u20131085 (2021).","journal-title":"Thyroid"},{"key":"86733_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1055\/a-1089-7870","volume":"52","author":"KA Araque","year":"2020","unstructured":"Araque, K. A., Gubbi, S. & Klubo-Gwiezdzinska, J. Updates on the management of thyroid Cancer. Horm. Metab. Res. 52, 562\u2013577 (2020).","journal-title":"Horm. Metab. Res."},{"key":"86733_CR9","doi-asserted-by":"publisher","first-page":"100825","DOI":"10.1016\/j.tvir.2022.100825","volume":"25","author":"P Pace-Asciak","year":"2022","unstructured":"Pace-Asciak, P., Russell, J. O. & Tufano, R. P. The treatment of thyroid Cancer with Radiofrequency ablation. Tech. Vasc Interv Radiol. 25, 100825 (2022).","journal-title":"Tech. Vasc Interv Radiol."},{"key":"86733_CR10","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1210\/clinem\/dgab836","volume":"107","author":"HR Nieto","year":"2022","unstructured":"Nieto, H. R. et al. Recurrence of papillary thyroid Cancer: a systematic Appraisal of Risk factors. J. Clin. Endocrinol. Metab. 107, 1392\u20131406 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"86733_CR11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.eprac.2021.09.006","volume":"27","author":"MR Haymart","year":"2021","unstructured":"Haymart, M. R. Progress and challenges in thyroid Cancer Management. Endocr. Pract. 27, 1260\u20131263 (2021).","journal-title":"Endocr. Pract."},{"key":"86733_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.nic.2021.04.010","volume":"31","author":"D Vinh","year":"2021","unstructured":"Vinh, D. & Zafereo, M. Surgical considerations in thyroid Cancer: what the Radiologist needs to know. Neuroimaging Clin. N Am. 31, 327\u2013335 (2021).","journal-title":"Neuroimaging Clin. N Am."},{"key":"86733_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.foodchem.2011.05.064","volume":"129","author":"S Qiao","year":"2011","unstructured":"Qiao, S. et al. Simultaneous quantification of flavonoids and phenolic acids in Herba Scutellariae barbatae and its confused plants by high performance liquid chromatography-tandem mass spectrometry. Food Chem. 129, 1297\u20131304 (2011).","journal-title":"Food Chem."},{"key":"86733_CR14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.carbpol.2012.03.084","volume":"89","author":"CL Ye","year":"2012","unstructured":"Ye, C. L. & Huang, Q. Extraction of polysaccharides from herbal Scutellaria Barbata D. Don (Ban-Zhi-Lian) and their antioxidant activity. Carbohydr. Polym. 89, 1131\u20131137 (2012).","journal-title":"Carbohydr. Polym."},{"key":"86733_CR15","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2147\/DMSO.S296164","volume":"14","author":"W Li","year":"2021","unstructured":"Li, W. & Xiao, H. Scutellaria Barbata D. Don Polysaccharides Inhibit High glucose-Induced Proliferation and Angiogenesis of Retinal Vascular endothelial cells. Diabetes Metab. Syndr. Obes. 14, 2431\u20132440 (2021).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"86733_CR16","doi-asserted-by":"crossref","unstructured":"Gong, B., Kao, Y., Zhang, C., Sun, F. & Zhao, H. Systematic Investigation of Scutellariae Barbatae Herba for Treating Hepatocellular Carcinoma based on Network Pharmacology. Evid. Based Complement. Alternat Med. 2018, 4365739 (2018).","DOI":"10.1155\/2018\/4365739"},{"key":"86733_CR17","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.lfs.2004.05.015","volume":"75","author":"X Yin","year":"2004","unstructured":"Yin, X., Zhou, J., Jie, C., Xing, D. & Zhang, Y. Anticancer activity and mechanism of Scutellaria Barbata extract on human lung cancer cell line A549. Life Sci. 75, 2233\u20132244 (2004).","journal-title":"Life Sci."},{"key":"86733_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0254-6272(08)60048-5","volume":"28","author":"Z Dai","year":"2008","unstructured":"Dai, Z. et al. The effect-enhancing and toxicity-reducing action of the extract of herba Scutellariae barbatae for chemotherapy in hepatoma H22 tumor-bearing mice. J. Tradit Chin. Med. 28, 205\u2013210 (2008).","journal-title":"J. Tradit Chin. Med."},{"key":"86733_CR19","unstructured":"Gen Ouyang1*, Y. Z. Zhehao Ouyang2, characteristics of TCM syndrome of 110 cases of postoperative thyroid carcinoma patients and their prescription medication. Liaoning J. Traditional Chin. Med. 41, 394\u2013400 (2014)."},{"key":"86733_CR20","doi-asserted-by":"crossref","unstructured":"Giuliani, C., Di Dalmazi, G., Bucci, I. & Napolitano, G. Quercetin and thyroid. Antioxid. (Basel) 13(10), 1202 (2024).","DOI":"10.3390\/antiox13101202"},{"key":"86733_CR21","doi-asserted-by":"crossref","unstructured":"Hong, Y. et al. Quercetin induces anticancer activity by upregulating Pro-NAG-1\/GDF15 in differentiated thyroid Cancer cells. Cancers (Basel) 13(12), 3022 (2021).","DOI":"10.3390\/cancers13123022"},{"key":"86733_CR22","doi-asserted-by":"crossref","unstructured":"Tang, H. et al. A Network Pharmacology Approach to uncover the pharmacological mechanism of XuanHuSuo Powder on Osteoarthritis. Evid. Based Complement. Alternat Med. 2016, 3246946 (2016).","DOI":"10.1155\/2016\/3246946"},{"key":"86733_CR23","doi-asserted-by":"crossref","unstructured":"Ru, J. et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform. 6, 13 (2014).","DOI":"10.1186\/1758-2946-6-13"},{"key":"86733_CR24","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. Integrated strategy for accurately screening biomarkers based on metabolomics coupled with network pharmacology. Talanta 211, 120710 (2020).","DOI":"10.1016\/j.talanta.2020.120710"},{"key":"86733_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jot.2023.01.002","volume":"39","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Pharmacological network analysis of the functions and mechanism of kaempferol from Du Zhong in intervertebral disc degeneration (IDD). J. Orthop. Translat. 39, 135\u2013146 (2023).","journal-title":"J. Orthop. Translat"},{"key":"86733_CR26","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"UniProt","year":"2023","unstructured":"UniProt. The Universal protein knowledgebase in 2023. Nucleic Acids Res. 51, D523\u2013d531 (2023).","journal-title":"Nucleic Acids Res."},{"key":"86733_CR27","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013w364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"86733_CR28","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 41, D991\u2013995 (2013).","journal-title":"Nucleic Acids Res."},{"key":"86733_CR29","doi-asserted-by":"publisher","first-page":"e13932","DOI":"10.7717\/peerj.13932","volume":"10","author":"J Zhao","year":"2022","unstructured":"Zhao, J. et al. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice. PeerJ 10, e13932 (2022).","journal-title":"PeerJ"},{"key":"86733_CR30","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"86733_CR31","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013d646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"86733_CR32","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis, G. Jr. et al. Database for annotation, visualization, and Integrated Discovery. Genome Biol. 4, P3 (2003).","journal-title":"Genome Biol."},{"key":"86733_CR33","doi-asserted-by":"crossref","unstructured":"Liu, Y., Chen, H. & Cui, H. Key Genes of Immunity Associated with Pterygium and Primary Sj\u00f6gren\u2019s Syndrome. Int. J. Mol. Sci. 24(3), 2047 (2023).","DOI":"10.3390\/ijms24032047"},{"key":"86733_CR34","unstructured":"The Gene Ontology. Resource: enriching a GOld mine. Nucleic Acids Res. 49, D325\u2013d334 (2021)."},{"key":"86733_CR35","doi-asserted-by":"crossref","unstructured":"Tomczak, K., Czerwi\u0144ska, P. & Wiznerowicz, M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol. (Pozn). 19, A68\u201377 (2015).","DOI":"10.5114\/wo.2014.47136"},{"key":"86733_CR36","first-page":"3848","volume":"110","author":"Z Wu","year":"2024","unstructured":"Wu, Z. et al. Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis. Int. J. Surg. 110, 3848\u20133878 (2024).","journal-title":"Int. J. Surg."},{"key":"86733_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13568-023-01640-w","volume":"13","author":"A Sakhawat","year":"2023","unstructured":"Sakhawat, A. et al. Natural compound targeting BDNF V66M variant: insights from in silico docking and molecular analysis. AMB Express. 13, 134 (2023).","journal-title":"AMB Express"},{"key":"86733_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-018-0903-0","volume":"17","author":"S Saini","year":"2018","unstructured":"Saini, S., Tulla, K., Maker, A. V., Burman, K. D. & Prabhakar, B. S. Therapeutic advances in anaplastic thyroid cancer: a current perspective. Mol. Cancer. 17, 154 (2018).","journal-title":"Mol. Cancer"},{"key":"86733_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jamasurg.2021.6442","volume":"157","author":"W Chen","year":"2022","unstructured":"Chen, W. et al. Association of total thyroidectomy or thyroid lobectomy with the quality of life in patients with differentiated thyroid Cancer with Low to Intermediate Risk of Recurrence. JAMA Surg. 157, 200\u2013209 (2022).","journal-title":"JAMA Surg."},{"key":"86733_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2214\/AJR.19.22626","volume":"215","author":"A Ciarallo","year":"2020","unstructured":"Ciarallo, A. & Rivera, J. Radioactive Iodine Therapy in differentiated thyroid Cancer: 2020 update. AJR Am. J. Roentgenol. 215, 285\u2013291 (2020).","journal-title":"AJR Am. J. Roentgenol."},{"key":"86733_CR41","doi-asserted-by":"publisher","first-page":"112260","DOI":"10.1016\/j.jep.2019.112260","volume":"254","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. A review of the ethnopharmacology, phytochemistry, pharmacology, and quality control of Scutellaria Barbata D. Don. J. Ethnopharmacol. 254, 112260 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"86733_CR42","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.7150\/thno.35219","volume":"9","author":"X Su","year":"2019","unstructured":"Su, X. et al. Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK\/ERK and PI3K\/AKT pathways via distinct mechanisms. Theranostics 9, 4461\u20134473 (2019).","journal-title":"Theranostics"},{"key":"86733_CR43","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1002\/iid3.796","volume":"11","author":"Q Jiang","year":"2023","unstructured":"Jiang, Q., Guan, Y., Zheng, J. & Lu, H. TBK1 promotes thyroid cancer progress by activating the PI3K\/Akt\/mTOR signaling pathway. Immun. Inflamm. Dis. 11, e796 (2023).","journal-title":"Immun. Inflamm. Dis."},{"key":"86733_CR44","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s40265-020-01394-w","volume":"80","author":"SE Nunnery","year":"2020","unstructured":"Nunnery, S. E. & Mayer, I. A. Targeting the PI3K\/AKT\/mTOR pathway in hormone-positive breast Cancer. Drugs 80, 1685\u20131697 (2020).","journal-title":"Drugs"},{"key":"86733_CR45","doi-asserted-by":"crossref","unstructured":"Stanciu, S. et al. Targeting PI3K\/AKT\/mTOR signaling pathway in pancreatic Cancer: from Molecular to clinical aspects. Int. J. Mol. Sci. 23(17), 10132 (2022).","DOI":"10.3390\/ijms231710132"},{"key":"86733_CR46","doi-asserted-by":"crossref","unstructured":"Maharati, A. & Moghbeli, M. PI3K\/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells. Cell. Commun. Signal. 21, 201 (2023).","DOI":"10.1186\/s12964-023-01225-x"},{"key":"86733_CR47","doi-asserted-by":"crossref","unstructured":"Li, J. et al. MiR-1246 regulates the PI3K\/AKT signaling pathway by targeting PIK3AP1 and inhibits thyroid cancer cell proliferation and tumor growth. Mol. Cell. Biochem. 477, 649\u2013661 (2022).","DOI":"10.1007\/s11010-021-04290-3"},{"key":"86733_CR48","doi-asserted-by":"crossref","unstructured":"Ke, S. et al. NKD2 trigger NF-\u03baB signaling pathway and facilitates thyroid Cancer Cell Proliferation. Mol. Biotechnol. 65, 1846\u20131856 (2023).","DOI":"10.1007\/s12033-023-00665-7"},{"key":"86733_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1476-4598-9-117","volume":"9","author":"KT Bauerle","year":"2010","unstructured":"Bauerle, K. T., Schweppe, R. E. & Haugen, B. R. Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion. Mol. Cancer. 9, 117 (2010).","journal-title":"Mol. Cancer"},{"key":"86733_CR50","doi-asserted-by":"crossref","unstructured":"Sun, Y. et al. To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments. Dis Markers 9541080 (2022). (2022).","DOI":"10.1155\/2022\/9541080"},{"key":"86733_CR51","doi-asserted-by":"publisher","first-page":"111266","DOI":"10.1016\/j.mce.2021.111266","volume":"529","author":"CFL Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves, C. F. L. et al. The flavonoid quercetin reduces cell migration and increases NIS and E-cadherin mRNA in the human thyroid cancer cell line BCPAP. Mol. Cell. Endocrinol. 529, 111266 (2021).","journal-title":"Mol. Cell. Endocrinol."},{"key":"86733_CR52","doi-asserted-by":"crossref","unstructured":"Shin, H. J., Hwang, K. A. & Choi, K. C. Antitumor Effect of Various Phytochemicals on Diverse Types of Thyroid Cancers. Nutrients 11, (2019).","DOI":"10.3390\/nu11010125"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86733-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86733-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86733-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T06:26:27Z","timestamp":1737354387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86733-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86733"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86733-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"22 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve any ethical issues.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"2490"}}